PegBio Co., Ltd. (PEGBIO CO-B) has issued the formal proxy for its 2025 annual general meeting, to be convened at 10:00 a.m. (Hong Kong time) on 24 June 2026. The hybrid session will be physically held at 6/F, Block A, No. 520 Shaoxing Road, Gongshu District, Hangzhou, Zhejiang Province, China.

Nine ordinary and three special resolutions are scheduled for shareholder approval:

1. Statutory Reports & Accounts • Board of Directors’ report, Supervisory Committee’s report, and the 2025 audited financial statements are slated for adoption. • A 2025 profit-distribution plan will be presented, details of which have yet to be disclosed in the proxy.

2. Operational Planning • The proposed 2026 annual financial budget will be tabled. • Remuneration packages for directors and supervisors for 2026 will be put to vote.

3. Corporate Governance • Appointment of a new independent non-executive director. • Re-appointment of the external auditor, with authority for the board to set audit fees.

4. Financing Flexibility • Management seeks approval to apply for credit facilities from financial institutions.

5. Capital Structure Adjustments (Special Resolutions) • An increase in registered capital accompanied by amendments to the articles of association. • A general mandate permitting the board to allot, issue and deal with new shares. • A separate mandate authorising the board to repurchase H shares.

Shareholders of record may appoint one or more proxies via Computershare Hong Kong Investor Services Limited; completed forms must be lodged no later than 10:00 a.m. on 23 June 2026. Physical attendance supersedes proxy instructions should shareholders elect to join the meeting in person.